Benefits
DashboardNot registered yet? Get a free account.
Sign UpNot registered yet? Get a free account.
Sign Up
You're about to leave our website and go to an external link. Are you sure?
Mankind Pharma Limited, is an unlisted public company incorporated on 03 July, 1991. It is classified as a public limited company and is located in South Delhi, Delhi. It's authorized share capital is INR 60.00 cr and the total paid-up capital is INR 40.06 cr.
Mankind Pharma Limited's operating revenue range is Over INR 500 cr for the financial year ending on 31 March, 2023. It's EBITDA has decreased by 5.68% over the previous year. At the same time, it's book networth has increased by 28.26%.
Read more
Buy Dashboard using Credits
This action will use 1 of your credits. Are you sure you want to go ahead?
Credits Balance:
0
** All rupee values in INR crores. Based on March 2023 numbers.
11.99%
-5.68%
-6.51%
28.26%
-99.32%
11.39%
-1.45
-3.91
-2.93
-5.96
-14.14
-0.11
Buy Report or Plans
Company dashboard
Five year financials and ratios
Risk analysis
Interactive charts
All financials
All annual returns
MoA and AoA
Latest financials
Latest annual return
MoA and AoA
Five year financials and ratios
Shareholding and group structure
Litigation and more
Everything in financial report
Peers and financials
* GST not included
** Reports & MCA filings will be based on the latest available financials.
India
(109)
| State | Type | Address |
|---|
Locations on Map
Filter (4)
Severe Risk
Moderate Risk
Low Risk
Read more
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Sales + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Sales growth % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Expenses + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cost of goods | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Employee cost | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other costs | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other income | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Depreciation | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Exceptional items | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit before tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit - disc. ops | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Solvency + | |||||
| Total Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Debt/Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Assets/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Liquidity + | |||||
| Current Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Quick Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest Coverage | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Performance | |||||
| Gross Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return + | |||||
| Return on Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROCE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return on Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROIC | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Efficiency + | |||||
| Days Payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Inventory | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Receivable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital | |||||
| Cash Conversion Cycle | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital Days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
CitiBank N.A.
No. of Loans: 1
Total Amount : 295.0 cr
HDFC Bank Limited
No. of Loans: 2
Total Amount : 260.0 cr
ICICI Bank Limited
No. of Loans: 1
Total Amount : 180.0 cr
Kotak Mahindra Bank Limited
No. of Loans: 1
Total Amount : 170.0 cr
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Surendra Lunia | 00121156 | 10 years |
| Whole-time Director | Ramesh Juneja
Shareholder
|
00283399 | 33 years |
| Managing Director | Rajeev Juneja
Shareholder
|
00283481 | 4 years |
| Director | Vivek Kalra | 00426240 | 2 years |
| Director | Vijaya Sampath | 00641110 | 2 years |
| Whole-time Director | Sheetal Arora
Shareholder
|
00704292 | 17 years |
| Kmp | Sheetal Arora | <HIDDEN> | 4 years |
| Director | Tilokchand Punamchand Ostwal | 00821268 | 5 years |
| CS | Pradeep Chugh | <HIDDEN> | 8 years |
| CFO | Ashutosh Dhawan | <HIDDEN> | 9 years |
| Director | Bharat Anand | 02806475 | 6 years |
| Whole-time Director | Satish Kumar Sharma | 07615602 | 8 years |
| Name | State / Country | Incorporation Year | Paidup Capital |
|---|---|---|---|
| Penta Latex LLP | India | - | - |
| MAHANANDA SPA AND RESORTS PRIVATE LIMITED | Uttarakhand | 2009 | ₹ 406.5 Cr |
| PACKTIME INNOVATIONS PRIVATE LIMITED | Delhi | 2015 | ₹ 25.0 Cr |
| JASPACK INDUSTRIES PRIVATE LIMITED | Delhi | 2015 | ₹ 156.0 Cr |
| Mankind Pharma Pte Ltd. | Singapore | - | - |
| Lifestar Pharma LLC | United States | - | - |
| APPIAN PROPERTIES PRIVATE LIMITED | Delhi | 2017 | ₹ 10.0 Cr |
| RELAX PHARMACEUTICALS PRIVATE LIMITED | Uttar Pradesh | 1997 | ₹ 30.0 L |
| COPMED PHARMACEUTICALS PRIVATE LIMITED | Delhi | 1988 | ₹ 96.0 L |
| LIFESTAR PHARMA PRIVATE LIMITED | Delhi | 2004 | ₹ 5.0 L |
| MEDIFORCE HEALTHCARE PRIVATE LIMITED | Uttar Pradesh | 2001 | ₹ 1.1 Cr |
| JPR LABS PRIVATE LIMITED | Delhi | 2010 | ₹ 49.7 Cr |
| Vetbesta Labs | India | - | - |
| Mankind Specialities | India | - | - |
| MAGNET LABS PRIVATE LIMITED | Delhi | 1998 | ₹ 4.0 L |
| BROADWAY HOSPITALITY SERVICES PRIVATE LIMITED | India | - | - |
| PAVI BUILDWELL PRIVATE LIMITED | Delhi | 2012 | ₹ 2.0 Cr |
| PROLIJUNE LIFESCIENCES PRIVATE LIMITED | India | - | - |
| SHREE JEE LABORATORY PRIVATE LIMITED | Delhi | 2011 | ₹ 140.5 Cr |
| MEDIPACK INNOVATIONS PRIVATE LIMITED | Delhi | 2012 | ₹ 6.0 Cr |
| Pharma Force Lab | India | - | - |
| PHARMAFORCE EXCIPIENTS PRIVATE LIMITED | Himachal Pradesh | 2019 | ₹ 9.0 Cr |
| MEDIFORCE RESEARCH PRIVATE LIMITED | Himachal Pradesh | 2019 | ₹ 5.0 Cr |
| Lifestar Pharmaceuticals | Nepal | - | - |
| QUALITEK STARCH PRIVATE LIMITED | Himachal Pradesh | 2019 | ₹ 24.9 Cr |
| Superba warehousing LLP | India | - | - |
| North East Pharma Pack | India | - | - |
| Packtime Global Packaging Materials Trading LLC | United Arab Emirates | - | - |
| MANKIND PRIME LABS PRIVATE LIMITED | Delhi | 2020 | ₹ 74.5 Cr |
| Mankind Life Sciences Private Limited | India | - | - |
| Appify Infotech Llp | India | - | - |
| MANKIND PETCARE PRIVATE LIMITED | Delhi | 2021 | ₹ 32.0 Cr |
| Mankind Pharma FZ LLC | United Arab Emirates | - | - |
| Broadway Hospitality Services Private Limited | India | - | - |
| Prolijune Lifesciences Private Limited | India | - | - |
| Pharma Force Labs (Partnership Firm) | India | - | - |
| Appify Infotech LLP | India | - | - |
The incorporation date of MANKIND PHARMA LIMITED is 03 July, 1991
The authorized share capital of MANKIND PHARMA LIMITED is INR ₹ 60.0 Cr.
The paid-up capital of MANKIND PHARMA LIMITED is INR ₹ 40.1 Cr.
The registered address of MANKIND PHARMA LIMITED is 208, Okhla Industrial Estate, Phase-III, NA New Delhi South Delhi Delhi - 110020
The CIN number of MANKIND PHARMA LIMITED is L74899DL1991PLC044843.
Expand
Delete
Collapse
See
details
